Last reviewed · How we verify
Guideline Directed Medical Therapy — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Guideline Directed Medical Therapy (Guideline Directed Medical Therapy) — Samsung Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Guideline Directed Medical Therapy TARGET | Guideline Directed Medical Therapy | Samsung Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Guideline Directed Medical Therapy CI watch — RSS
- Guideline Directed Medical Therapy CI watch — Atom
- Guideline Directed Medical Therapy CI watch — JSON
- Guideline Directed Medical Therapy alone — RSS
Cite this brief
Drug Landscape (2026). Guideline Directed Medical Therapy — Competitive Intelligence Brief. https://druglandscape.com/ci/guideline-directed-medical-therapy. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab